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ABSTRACT
Objective To assess incidence and burden of neonatal 
herpes simplex virus (HSV) infections and to explore 
possible transmission routes.
Methods A 2- year prospective nationwide surveillance 
study performed in 2017 and 2018. All German 
paediatric departments (n=464 in 2017, n=441 in 
2018) were contacted on a monthly basis to report 
potential cases of neonatal HSV infections. Infants with 
a postnatal age of ≤60 days and a positive HSV PCR 
or HSV culture from skin, mucous membrane, vesicles 
or conjunctival smear, blood or cerebrospinal fluid were 
included in the study.
Results 37 cases were analysed. 29 patients who 
exhibited no or only mild clinical symptoms were 
discharged home without organ damage or neurological 
abnormalities. Four patients showed significant 
neurological impairment, one patient required liver 
transplantation and two patients died during in- patient 
treatment. The 2- year incidence of neonatal HSV 
infections was 2.35 per 100 000 live births (95% CI 
1.69 to 3.02) and disease- specific mortality was 0.13 
per 100 000 live births (95% CI 0.04 to 0.21). Data on 
possible transmission routes were available in 23 cases. 
In 20 cases, an orofacial HSV infection was present in 
one or more family members. An active maternal genital 
HSV infection was reported in 3 cases.
Conclusion Neonatal HSV infections are rare in 
Germany. Most infants have a benign clinical course, 
but some infants are severely affected. Postnatal HSV 
exposure may account for a considerable number of 
neonatal HSV infections.
INTRODUCTION
Neonatal herpes simplex virus (HSV) infections 
are rare. In the USA and Canada, the incidence 
has been estimated to be around 6–10 cases per 
100 000 live births.1 2 It is commonly assumed that 
about 85% of infants become infected in the intra-
partum period, 10% postnatally and 5% in utero.3 
However, in many cases, the exact mode of trans-
mission cannot be determined.2 Neonatal HSV 
infections are usually apparent before 14 days of 
life, but later manifestations have been described.
The two specific types of HSV, HSV-1 and 
HSV-2, both cause neonatal infections.4 Mother- 
to- child transmission is significantly increased 
in primary versus recurrent maternal infections, 
during vaginal delivery versus caesarean section and 
in infection with HSV-1 versus HSV-2.5 Maternal 
HSV type- specific serology allows risk- adapted 
treatment in cases with a high risk of transmis-
sion.6 In Germany, estimates of HSV seropreva-
lence in adults are about 78%–83% for HSV-1 and 
10%–13% for HSV-2.7–9 Although seroprevalence 
has tended to decrease over the past two decades, 
this decrease may pose a threat to neonates because, 
concomitantly, susceptibility to HSV infection may 
increase in the perinatal period.5 9 10
Three major disease manifestations of neonatal 
HSV infection occur: (1) skin, mucosa and conjunc-
tival disease; (2) central nervous system (CNS) 
disease; (3) disseminated disease with multiple 
organ involvement. Neonatal HSV infections may 
present with classic symptoms (herpetic skin and 
mucosal lesions, seizures), but symptoms may also 
be nonspecific (fever, poor drinking, lethargy) or 
absent.11 Timely diagnosis is challenging but crucial 
to avoid a delay in the initiation of antiviral therapy. 
Neonatal HSV infections can have a high morbidity 
and mortality. Delayed initiation of therapy has 
been associated with poorer outcomes.12 13 The 
actual incidence of neonatal HSV infections in 
Europe, especially in Germany, is insufficiently 
evaluated. There are also limited data available 
What is already known on this topic?
 ► Neonatal herpes simplex virus (HSV) infections 
are rare but associated with a high morbidity 
and lethality.
 ► Maternal genital HSV infection is the most 
common source of infection.
What this study adds?
 ► Horizontal transmission via mothers and family 
members may be a possible source of neonatal 
HSV infection.
 ► Neonates treated for asymptomatic or skin/
mucous membrane HSV infections have a 
favourable outcome, while neonates presenting 
with disseminated disease or eye infection are 
at high risk for sequelae.
 ► An urgent need exists for extended HSV 
serology and direct virus detection in mothers, 
neonates, and family members to assess 
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on disease burden, routes of transmission and the frequency of 
nosocomial neonatal HSV infections. The aim of this study was 
to assess incidence and burden of neonatal HSV infections and 
to explore possible transmission routes.
METHODS
Design
This 2- year prospective nationwide surveillance study was 
performed in 2017 and 2018. All German paediatric departments 
(n=464 in 2017, n=441 in 2018) were contacted on a monthly 
basis to report potential cases of neonatal HSV infections. Data 
were collected via the German Paediatric Surveillance Unit 
for Rare Diseases (ESPED—in German: Erhebungseinheit für 
Seltene Pädiatrische Erkrankungen in Deutschland), a voluntary 
reporting system that covers all German paediatric departments. 
Following each initial case report, a detailed clinical question-
naire was sent out to the reporting department by ESPED.
The questionnaire included perinatal characteristics, clinical 
symptoms, diagnostic findings and outcome data. In addition, 
the questionnaire asked about possible routes of transmission 
(active maternal genital HSV infection: first or recurring; active 
non- genital HSV infection: mother, father, siblings, other house-
hold members).
Case definition/ inclusion criteria
Infants with a postnatal age of ≤60 days and a positive HSV 
PCR or HSV culture from skin, mucous membranes, vesicles 
or conjunctival smear, blood or cerebrospinal fluid (CSF) were 
included in the study.
Secondary data sources
To assess underreporting in the incidence of neonatal HSV infec-
tions, an additional dataset was generated using the validated 
hospital discharge records (coded by the respective ICD-10 code 
P35.2) reported to the German Federal Statistical Office by the 
statutory health insurances as the second source. An inquiry was 
performed for the frequency of the prespecified diagnosis P35.2 
“congenital infection due to herpes viruses” in infants with 
a postnatal age of ≤1 year in the years 2017 and 2018 (data 
requested from https://www. gbe- bund. de/ gbe/; 11 September 
2020).
Statistical analysis
Data entry, cleaning and evaluation were performed using IBM 
SPSS Statistics V.25. Characteristics of the patients and their 
mothers were expressed by means for continuous variables and 
by relative and absolute frequencies for discrete variables.
To estimate the extent to which the ESPED sample was repre-
sentative, we planned a two- source capture–recapture calcu-
lation. Because one of the underlying basic assumptions of a 
capture–recapture calculation was violated, the distribution of 
some characteristics was compared with the health insurance 
data. The numbers of patients were extrapolated to the German 
live born infants in 2017 and 2018 (Federal Statistical Office, 
Wiesbaden 2020), and the 2- year incidence of neonatal HSV 
infections per 100 000 live born infants for the years 2017 and 
2018 was calculated with 95% CI. For comparison with the data 
of our cohort study, we also present the incidence of neonatal 
HSV infections per 100 000 live born infants with the health 
data reported to the German Federal Statistical Office by the 
statutory health insurances companies.
RESULTS
Incidence
There were 48 initially reported cases in 2017 and 2018. The 
case definition was not fulfilled in three cases, and in another 
eight cases the questionnaires were not sent back. Thus, a total 
of 37 affected infants, including one pair of twins, were anal-
ysed. Perinatal characteristics are presented in table 1. The 2- year 
incidence of neonatal HSV infections was 2.35 per 100 000 live 
births (95% CI 1.69 to 3.02). This result was in line with the 
health data reported to the German Federal Statistical Office by 
the statutory health insurance companies. Retrospective analysis 
of the period from 2017 to 2018 resulted in 60 cases with a 
diagnosis of “congenital infection due to herpes viruses”. This 
corresponded to an incidence of 3.83 per 100 000 live births.
Distribution of HSV subtypes
In most cases (18 infants), infection with HSV type 1 was present. 
Type 2 was detected in four infants, and mixed infection with 
HSV types 1 and 2 occurred in two infants. In the remaining 13 
cases, no subtype determination was performed, or the result 
was unknown. HSV subtype 2, which is associated with genital 
herpes, CNS infection or disseminated infection in adults, was 
exclusively detected in infants with eye infection. HSV subtype 1 
was present in all types of infections.





  Male 20
  Female 17
Gestation
  Term 29
  Preterm 7
  N/A 1
Age at onset of symptoms*
  Day of life, median (min, max) 10 (0, 52)
Days between onset of symptoms and start of antiviral treatment*




  20–35 30
  >35 2
  <20 4
Birth mode
  Vaginal 22
  Vaginal- instrumental 4
  Caesarean section 4
  N/A 6
Rupture of membranes >18 hours before birth
  Yes 2
  No 16
  N/A 18
*Available for the 27/37 infants that were symptomatic.
†Total number is 36 for the mothers since a pair of twins was included in the 
survey. For child- related factors, this mother is included in the calculations for each 
child individually.
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Antiviral therapy
Therapy of all neonatal HSV infections was with acyclovir, with 
doses ranging from 13 to 70 mg/kg/day. In two infants, the doses 
were not reported. The duration of therapy ranged from 4 to 
205 days, with a median of 14 days. In two infants, the duration 
of therapy was not reported.
Hospital stays
Most infants (28) were solely treated on general paediatric wards 
while 8 infants received treatment in intensive care units. The 
median duration of hospital stay was 14 days, with a minimum 
of 2 days and a maximum of 73 days. Length of hospital stays 
and inpatient assignment were not reported for two patients 
each.
Possible transmission routes and risk factors
Data on possible transmission routes were available for 23 
infants. In 20 cases, an orofacial HSV infection was present in 
one or more family members (mothers in 15 cases, fathers in 
3 cases, both parents in 1 case and a sibling in 1 case). Labial 
herpes was reported in 17 cases, one mother was affected by 
nasal herpes and another had periorbital herpes. In one case, a 
mother of affected twins had labial herpes.
An active genital HSV infection was reported from three 
mothers. Twenty- six mothers definitely did not reveal symptoms 
of a genital HSV infection, while the status was unknown in 
seven mothers. None of the mothers was reported to have been 
treated with acyclovir before or during delivery to prevent trans-
mission of the herpes virus.
Table 2 Virological profiles of affected infants, mothers and other household members
Case number




Localisation of HSV 
detection* HSV subtype HSV copies/mL
Active maternal or household 
HSV infection
1 6 No CSF 2 N/A Mother, labial herpes
2 5 No CSF 1 N/A None reported
3 30 No CSF 1 N/A Mother, labial herpes
4 N/A Yes Mucocutaneous N/A N/A Mother, labial herpes
5 5 No CSF 2 N/A None reported
6 1 Yes Blood 1 5.8×102 Mother, labial herpes
7 18 No Blood N/A N/A None reported
8† N/A Yes Mucocutaneous N/A N/A Mother, labial herpes
9† N/A Yes Mucocutaneous N/A N/A Mother, labial herpes
10 N/A Yes Mucocutaneous N/A N/A Mother, various mucocutaneous 
lesions
11 6 No Blood N/A N/A None reported
12 N/A Yes Mucocutaneous N/A N/A Mother, labial herpes
13 19 No Blood N/A N/A Father, labial herpes
14 3 Yes Blood 1 5×106 None reported
15 2 Yes Mucocutaneous 1 N/A Father, labial herpes
16 34 No Blood 1 N/A Mother, labial herpes
17 7 No Mucocutaneous 1 N/A Mother, labial herpes
18 21 No CSF 1 4.3×102 None reported
19 13 No Mucocutaneous 1 N/A Father, labial herpes
20 9 No Mucocutaneous 1 N/A Mother, labial herpes
21 52 No Mucocutaneous N/A N/A Sibling, labial herpes
22 3 No CSF 2 N/A None reported
23 2 Yes Blood 1 4.5×106 None reported
24 6 No Mucocutaneous 1 N/A None reported
25 9 No CSF 2 5.7×103 None reported
26 21 No Mucocutaneous 1 N/A None reported
27 0 Yes Mucocutaneous 1 N/A None reported
28 8 Yes Blood 1 N/A None reported
29 N/A Yes Mucocutaneous 1 N/A Mother, genital herpes
30 N/A No Mucocutaneous 1 N/A Mother, labial herpes
31 14 No Mucocutaneous 1 6.7×103 Mother, labial herpes
32 N/A No Mucocutaneous N/A N/A Mother, various mucocutaneous 
lesions
33 N/A No Mucocutaneous 1 and 2 N/A Mother, genital herpes
34 N/A No Mucocutaneous N/A N/A Mother, labial herpes
35 12 No Mucocutaneous N/A N/A None reported
36 35 No Mucocutaneous N/A N/A Mother, labial herpes
37 25 No Blood 1 and 2 N/A Mother, genital herpes
*All tests performed via PCR.
†Twins.
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Table 2 summarises the virological profiles of the affected 
infants and their families.
Clinical symptoms and outcomes
During the study period, two deaths associated with neonatal 
HSV infection were reported. One of those infants was also diag-
nosed with an inborn error of metabolism, likely contributing to 
the fatal outcome. The two deaths resulted in a case fatality rate 
of 5.4% (95% CI 1.37 to 6.97) and a disease- specific mortality 
rate of 0.13 per 100 000 live births (95% CI 0.04 to 0.21).
Ten infants were asymptomatic. Fifteen infants presented with 
one isolated symptom and 12 infants presented with a combina-
tion of two to five symptoms. Details on disease manifestation 
and symptoms are given in table 3.
Twenty- nine infants were healthy at discharge, while five 
infants had significant sequelae. Four of them showed signifi-
cant neurological impairment, and one had a liver transplant. 
In one case, the outcome was unknown, as the infant was trans-
ferred to another hospital without further information available. 
Half of the infants who presented with disseminated disease had 
sequelae, as did 37.5% of those with eye infection. Almost all 
(97.3%) infants with a skin or mucous membrane lesion and all 
asymptomatic infants were healthy at discharge.
DISCUSSION
The incidence of neonatal HSV infections has been previously 
estimated to range from 1.4 to 4.7 per 100 000 live births in 
Switzerland, Australia and the Netherlands14–17; and up to 5.9, 
8.4 and 12.1 per 100 000 live births in Canada, Israel and the 
USA.2 18 19 Globally, the incidence is estimated to be around 10 
per 100 000 live births.20 We report an incidence at the lower 
end of this spectrum for Germany (2.35 per 100 000). The 
different study results appear comparable, even though study 
designs and definitions of neonatal HSV infection vary across 
studies. Differences between regions and countries are largely 
unknown but are likely attributable to cultural differences or 
differences in primary healthcare settings. Compared with other 
studies, reporting case fatality rates of 19% to 26%, death from 
neonatal HSV infection was low in our study.17 21
It is commonly assumed that most neonatal HSV infections 
occur in the intrapartum period and that postnatal transmis-
sions are rare incidents.3 14 22 However, HSV transmission 
routes have been insufficiently evaluated in prospective studies. 
As with incidence, transmission routes may also vary signifi-
cantly between countries and regions. In our study, symp-
toms of maternal genital HSV infections were rarely reported, 
while non- genital HSV infections of household members were 
frequent among affected neonates. Possible postnatal trans-
mission of HSV via household members has been suggested in 
various case reports23–28 and also in one large study from Jones 
et al.17 Our study supports this suggestion, but cannot defi-
nitely prove this mode of transmission due to lack of molecular 
testing. Future studies will need to incorporate comprehensive 
maternal antibody testing and molecular genetic techniques to 
explore preventive factors and to further elucidate sources of 
neonatal HSV infections.
HSV-1 was detected in the majority of infections. This is in 
contrast to high maternal and neonatal HSV-2 infection rates 
in other parts of the world.20 These results indicate regional 
differences in the epidemiology of neonatal HSV infections. In 
Germany, it appears that awareness of maternal genital HSV 
infections is high, and that prenatal care may have improved 
over time, while postnatal HSV exposure may be more common. 
However, vertical transmission may have been underestimated 
in this study since transmission occurring in the birth canal is 
also possible in the absence of active genital HSV lesions.29 
HSV shedding around birth can also occur with asymptomatic 
reactivation and only be estimated adequately, if direct virus 
monitoring is performed in particular on the basis of previously 
reported episodes of genital HSV.4
Our study adds evidence to the possibility of postnatal HSV 
exposure. Neonates are at risk of acquiring HSV infections from 
family members or others with skin or mucous membrane infec-
tions. More research is needed to evaluate strategies of empirical 
antiviral therapy of exposed infants, including those with no or 
mild symptoms. Based on the available evidence, families should 
receive comprehensive counselling, and preventive measures, 
Table 3 Clinical and diagnostic characteristics of neonates with 
HSV infection in Germany 2017–2018
Category of disease Number of infants*
  Mucocutaneous 21
  Eye 8
  CNS 2
  Disseminated 4
  Not reported 2
Clinical symptoms
  No symptoms 10
  Mucocutaneous herpes blisters 10
  Poor feeding 7
  Circulatory problems 7
  Body temperature >38.0°C 5
  Seizures 6
  Dyspnoea or tachypnoea 6
  Apnoea 5
  Lethargy 4
  Unspecific symptoms 6
Laboratory findings
  No abnormal findings 21
  Elevated liver enzymes 10
  Leucocyte count >15/nL 7
  Thrombocytopenia <150/nL 5
  Abnormal coagulation 4
  CRP >15 mg/L 4
  CSF cell count >20/nL (0–28 DOL), >9/nL (29–60 DOL) 3
  CSF glucose <40 mg/dL 2
  Leucocyte count <5/nL 1
Diagnostics
Cranial ultrasound
  Normal 23
  Abnormal 4
  Not performed/unknown 10
Cranial MRI
  Normal 3
  Abnormal 5
  Not performed 29
EEG
  Normal 2
  Abnormal 6
  Not performed 29
*Multiple answers possible.
CNS, central nervous system; CRP, C reactive protein; CSF, cerebrospinal fluid; DOL, 
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especially avoidance of contact with herpetic blisters, should be 
liberally implemented.30
We found seven infants with serious adverse outcomes. Our 
findings that infants with skin/mucous membrane infection 
commonly had good outcome at discharge, but that many 
infants with disseminated disease had sequelae, warrant further 
confirmatory investigations. However, we suggest that parents 
of infants presenting with no or only mild symptoms and who 
are on antiviral treatment may be reassured.
In summary, neonatal HSV infections are rare in Germany. 
The vast majority of infections are skin/mucous membrane 
infections with a mild clinical course and very good outcome. 
Nevertheless, HSV infections can be extremely severe in indi-
vidual cases and cause permanent severe impairment. Horizontal 
infection within the family may be a possible transmission route. 
Neonatal HSV infection is for both mothers and infants, as well 
as family members, an interdisciplinary diagnosis. Inclusion of 
specific maternal and infant virological data is a prerequisite for 
urgently needed multi- national studies to increase our knowl-
edge on recognition and prevention of neonatal HSV infections.
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